PADI2 and myeloid sarcoma: In neurodegenerative diseases, aberrant PAD2 activity and protein citrullination have been shown in Alzheimer’s disease (AD), Parkinson’s disease (PD), prion diseases, multiple sclerosis (MS), ischemic and traumatic brain injuries [11-16], and recently, in ALS [17,18].